Henlius Biotech Raises $410 Million in Hong Kong IPO

(Bloomberg) -- Shanghai Henlius Biotech Inc. priced its Hong Kong initial public offering at the bottom of the marketed range, raising $410 million in the city’s first major listing since July.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.